EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury

Ehab E Sharata, Mina Ezzat Attya, Marwa M Khalaf, Remon Roshdy Rofaeil, Amira M Abo-Youssef, Ramadan Am Hemeida

Food and Chemical Toxicology · 2025-11 · 205 · 115719

DOI: 10.1016/j.fct.2025.115719 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2025-11. Verfasst von Ehab E Sharata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. Electronic address: ehab.essam@deraya.edu.eg. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Cyclophosphamide, Ovary, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 289 Literaturangaben. Gefördert von: Canadian Physiotherapy Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) is a complex condition characterized by the termination of ovarian function before the age of 40, affecting approximately 1 % of women within this age group. This review offers a comprehensive overview of POI aspects, including its definition, epidemiology, clinical presentations, etiological factors, diagnostic approaches, complications, and management strategies. A particular emphasis is placed on cyclophosphamide (CPA), an alkylating agent widely used in cancer and autoimmune disease treatment, which is known to cause serious ovarian toxicity leading to POI. The review explores the molecular mechanisms underlying CPA-induced ovarian injury, highlighting the roles of oxidative stress, inflammatory responses, and apoptosis. Key signaling pathways, including TLR4/MYD88/NF-κB, NLRP3 inflammasome, Nrf2/HO-1, α-klotho, and several implicated pathways, are discussed with respect to their contributions to ovarian damage and potential as therapeutic targets. This study seeks to consolidate all data about POI aspects, focusing on the molecular pathways underlying CPA-induced POI and recent pharmacological and natural drugs that showed a protective impact against CPA provoked ovarian injury. Additionally, the impact of CPA on male infertility is discussed. In conclusion, studying these molecular pathways might open the way for early alleviation of POI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyCyclophosphamideOvaryAntineoplastic Agents, AlkylatingHumansFemaleAnimalsOxidative Stress

Stichwörter der Autor:innen

CyclophosphamideHO-1NLRP3 inflammasomeNrf2Premature ovarian insufficiencyα-klotho

Substanzen

CyclophosphamideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. Electronic address: ehab.essam@deraya.edu.eg.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia, 61519, Egypt. Electronic address: mena.ezzat@mu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: marwa.khalaf@pharm.bsu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt; Department of Medical Pharmacology, Faculty of Medicine, Minia University, Minia, 61519, Egypt. Electronic address: r…
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: amira.abouyousif@pharm.bsu.edu.eg.
  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, Minia, 61111, Egypt. Electronic address: ramadan.hemeida@deraya.edu.eg.

Förderung

  • Canadian Physiotherapy Association

Zitieren

APA

Sharata, E. E., Attya, M. E., Khalaf, M. M., Rofaeil, R. R., Abo-Youssef, A. M., & Hemeida, R. A. (2025). Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury. Food and Chemical Toxicology, 205, 115719. https://doi.org/10.1016/j.fct.2025.115719

Vancouver

Sharata EE, Attya ME, Khalaf MM, Rofaeil RR, Abo-Youssef AM, Hemeida RA. Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury. Food and Chemical Toxicology. 2025;205:115719. doi:10.1016/j.fct.2025.115719

BibTeX
@article{Sharata2025,
  author = {Sharata, Ehab E and Attya, Mina Ezzat and Khalaf, Marwa M and Rofaeil, Remon Roshdy and Abo-Youssef, Amira M and Hemeida, Ramadan Am},
  title = {Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury},
  journal = {Food and Chemical Toxicology},
  year = {2025},
  volume = {205},
  pages = {115719},
  doi = {10.1016/j.fct.2025.115719}
}
Kostenlos starten →